[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341302-105":59,"doc-detail-341302-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","integrating-plasma-protein-centric-multi-omics-to-identify-potential-therapeutic-targets-for-pancreatic-cancer","Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer","","Genetic evidence is used to map circulating, plasma protein signals to pancreatic cancer (PC) susceptibility and to nominate druggable therapeutic targets. The study applies proteome-wide Mendelian randomization using cis-pQTLs from multiple centers, supported by sensitivity testing, colocalization, reverse MR, replications with varied instruments and external datasets, and meta-analysis. Single-cell expression, pathway enrichment, interaction/cause analyses, knockout mice, mediation, and phenome-wide MR prioritize candidates, including drugs potentially repurposable for PC. ",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-plasma-protein-centric-multi-omics-to-identify-potential-therapeutic-targets-for-pancreatic-cancer/341302/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-plasma-protein-centric-multi-omics-to-identify-potential-therapeutic-targets-for-pancreatic-cancer/341302.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of integrating plasma protein-centric multi-omics in this study?","Question",{"text":113,"@type":114},"To determine how genetically influenced plasma proteins relate to pancreatic cancer risk and to identify potential therapeutic targets for diagnosis and treatment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study assess whether the observed protein associations are robust and causal?",{"text":118,"@type":114},"It used proteome-wide Mendelian randomization with multiple sensitivity analyses, colocalization, reverse MR, replications using different instrumental variable selections and additional datasets, and subsequent meta-analysis.",{"name":120,"@type":111,"acceptedAnswer":121},"How were candidate targets prioritized for drug development and safety considerations?",{"text":122,"@type":114},"After identifying PC-related proteins, the study prioritized candidates based on druggability and potential side effects predicted by phenome-wide Mendelian randomization, while also checking broader trait associations and malignancy risks.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341302,1790420005,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Zhou et al. Journal of Translational Medicine (2024) 22:557  \n[https://doi.org/10.1186/s12967-024-05363-9](https://doi.org/10.1186/s12967-024-05363-9)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nIntegrating plasma protein-centric    \nmulti-omics to identify potential therapeutic targets for pancreatic cancer  \nSiyu Zhou1†, Baian Tao1†, Yujie Guo1†, Jichun Gu1, Hengchao Li1, Caifeng Zou1, Sichong Tang2, Shuheng Jiang3*, Deliang Fu 1* and Ji Li 1*  \nAbstract  \nBackground Deciphering the role of plasma proteins in pancreatic cancer (PC) susceptibility can aid in identifying novel targets for diagnosis and treatment.  \nMethods We examined the relationship between genetically determined levels of plasma proteins and PC through a systemic proteome-wide Mendelian randomization (MR) analysis utilizing cis-pQTLs from multiple centers. Rigorous sensitivity analyses, colocalization, reverse MR, replications with varying instrumental variable selectionsand additional datasets, as well as subsequent meta-analysis, were utilized to confirm the robustness of significant findings. The causative effect of corresponding protein-coding genes’ expression and their expression pattern in single-cell types were then investigated. Enrichment analysis, between-protein interaction and causation, knockout mice models, and mediation analysis with established PC risk factors were applied to indicate the pathogenetic pathways. These candidate targets were ultimately prioritized upon druggability and potential side effects predicted by a phenome-wide MR.  \nResults Twenty-one PC-related circulating proteins were identified in the exploratory phase with no evidence for horizontal pleiotropy or reverse causation. Of these, 11 were confirmed in a meta-analysis integrating external validations. The causality at a transcription level was repeated for neutrophil elastase, hydroxyacylglutathione hydrolase, lipase member N, protein disulfide-isomerase A5, xyloside xylosyltransferase 1. The carbohydrate sulfotransferase 11 and histo-blood group ABO system transferase exhibited high-support genetic colocalization evidence and were found to affect PC carcinogenesis partially through modulating body mass index and type 2 diabetes, respectively. Approved drugs have been established for eight candidate targets, which could potentially be repurposed for PC therapies. The phenome-wide investigation revealed 12 proteins associated with 51 non-PC traits, and interference on protein disulfide-isomerase A5 and cystatin-D would increase the risk of other malignancies.  \n†Siyu Zhou, Baian Tao, and Yujie Guo contributed equally to this study.  \n*Correspondence: Shuheng Jiang [shjiang@shsci.org](shjiang@shsci.org)[ ](shjiang@shsci.org)Deliang Fu [surgeonfu@163.com](surgeonfu@163.com)[ ](surgeonfu@163.com)Ji Li[liji@huashan.org.cn](liji@huashan.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org","cbCailY0qDEID50l","https://ap.wps.com/l/cbCailY0qDEID50l","pdf",4488403,17,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What is the main goal of integrating plasma protein-centric multi-omics in this study?\",\"answer\":\"To determine how genetically influenced plasma proteins relate to pancreatic cancer risk and to identify potential therapeutic targets for diagnosis and treatment.\"},{\"question\":\"How did the study assess whether the observed protein associations are robust and causal?\",\"answer\":\"It used proteome-wide Mendelian randomization with multiple sensitivity analyses, colocalization, reverse MR, replications using different instrumental variable selections and additional datasets, and subsequent meta-analysis.\"},{\"question\":\"How were candidate targets prioritized for drug development and safety considerations?\",\"answer\":\"After identifying PC-related proteins, the study prioritized candidates based on druggability and potential side effects predicted by phenome-wide Mendelian randomization, while also checking broader trait associations and malignancy risks.\"}]","Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer | PDF",1790041431,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/075943fdf7855de88330c95254f4b322.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87bec69bfa969c770ead011c76627680.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79cc7fc7759c4f7d74662bb6aba7cd83.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ee1f876b02a7b21bb4eac108eaa1276.webp",980,1301]